Save the Date for Grand Rounds Guest Speaker Matthias A. Karajannis!
Save the Date! Neurology Grand Rounds Guest Speaker Matthias A. Karajannis, MD, MS Pediatric Neuro-Oncologist May 11, 2021 12pm – 1:00 Neurofibromatosis Type 2…
Posted in
NF Clinic
Advances in Neurofibromatosis: Integrating Multi-modality Therapy
Live Virtual CME Experience Friday, October 9, 2020 (8:45 am-4:15 pm) This live virtual conference is intended to provide an update on current evaluation and multi-modality therapy for neurofibromatosis. Neurofibromatosis represents a group of inheritable disorders that require multi-disciplinary integrated care. Major advances in defining molecular alterations and…
NF1 in Adults and Genetic Predisposition to Neoplasms
Xia Wang, MD, PhD Neurofibromatosis Clinic Moffitt Cancer Center 12902 USF Magnolia Drive Tampa, FL …
Join us for a Virtual Event!
Overview of Neurofibromatosis Type 1 Plexiform Neurofibroma Speaker: Dr. Mislen Bauer Director, Neurofibromatosis Program Clinical Genetics & Metabolism Nicklaus Children’s Hospital, Miami FL Date: June 12, 2020 12:00 – 1:00 pm EDT To register please click here!…
Virtual NF Conference – June 15-16!
Please join us for the upcoming virtual NF conference brought to you by the Children’s Tumor Foundation – June 15-16, 2020! The conference kicks off at 9:45 ET Monday with a welcome from our co-chairs and opening remarks from Dr. Francis Collins of the NIH. The Clinical Care Advisory Board…
The Evolving Treatment Landscape of NF1-Associated Tumors
A Medscape Live Event! Sunday, May 31, 2020 5:00 – 6:00 PM Eastern Daylight Time See Brochure here!…
Understanding NF2
Use this link to download a copy of NF Hero Comics – Understanding NF2. This is a resource from the Children’s Tumor Foundation – Ending NF through Research. …
Speaker Announcement – Sepideh Mokhtari, MD
Tuesday January 7, 2020 12 pm- 1 pm Invited Neurology Grand Rounds Speaker Sepideh Mokhtari MD Neuro-oncological Aspects of Neurofibromatosis Location: McKnight Brain Institute, DeWeese Auditorium, LG-101 Dr. Sepideh Mokhtari is an Assistant Member in the Department of Neuro-Oncology at Moffitt Cancer Center. Dr. Mokhtari received her…
Care of adults with neurofibromatosis type 1
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor-predisposition disorder that arises from loss-of function variants in the tumor-suppressor gene NF11,2. Features of the disorder typically appear in early childhood. Download article now…
Breakthrough News…
New Study reveals treatment pathway for Neurofibromatosis Now, a national team of researchers including James Wymer, M.D., Ph.D., a UF professor of neurology and director of the neuromuscular division, has identified a novel pathway for potential treatment of this distressing condition, which typically is diagnosed in childhood or early adulthood.
